New meta-analysis shows that pirfenidone in idiopathic pulmonary fibrosis (IPF) may provide dual protection: (1) slowing fibrosis progression, and (2) reducing lung cancer risk. Pirfenidone's impact on cough as a key symptom in patients with IPF is yet to be measured objectively.
Published 2 hours ago
Source: reddit.com
Categories
science
Related Articles from reddit.com
37 minutes ago
France replaces US as main intelligence provider to Kyiv, Macron says
41 minutes ago
X Is Down: Thousands of Users Report Outage on Social Media Platform
1 hour ago
A study of 2,801 Germans finds that learning about widespread support for climate action corrects perceptions of public opinion but fails to change personal beliefs or behaviors. These findings challenge the strategy of using social consensus messaging to drive individual climate action.
1 hour ago
How ageing harms the body’s response to raging infection
1 hour ago
Italian regulators are investigating Activision Blizzard's monetization practices
2 hours ago